A Phase IIa, Placebo Controlled, Multicenter Pilot Study to Evaluate the Safety and Efficacy of BIO-11006 Inhalation Solution in Patients With Acute Respiratory Distress Syndrome

Trial Profile

A Phase IIa, Placebo Controlled, Multicenter Pilot Study to Evaluate the Safety and Efficacy of BIO-11006 Inhalation Solution in Patients With Acute Respiratory Distress Syndrome

Recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Jul 2018

At a glance

  • Drugs BIO-11006 (Primary)
  • Indications Respiratory distress syndrome
  • Focus Adverse reactions; Proof of concept
  • Sponsors BioMarck Pharmaceuticals
  • Most Recent Events

    • 13 Feb 2018 Planned End Date changed from 1 Jun 2018 to 1 Dec 2018.
    • 13 Feb 2018 Planned primary completion date changed from 31 Dec 2017 to 31 Aug 2018.
    • 02 Oct 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top